Senior Director, Therapeutic Cell Production Core/Quality Assurance
Catherine Lindgren is responsible for directing the manufacturing, and quality control operations of the TCPC and ensuring that compliance to strict quality assurance parameters are met. She has more than 30 years of laboratory research experience moving promising new discoveries from the research bench into human clinical cancer research trials, and over 15 years of experience in GMP quality assurance, overseeing the manufacturing and release of therapeutics for cell-based clinical trials. She came to the TCPC after overseeing similar facilities at the University of Washington and Fred Hutchinson Cancer Research Center. She holds a BS from Washington State University and a certification in biomedical regulatory affairs from the University of Washington.
Director, GMP Cell Production
Chris Brown leads the TCPC's manufacturing/process development team and played a key role in development and startup of the TCPC and its clean room facility. He has more than 17 years of experience in the manufacturing of cellular products for Phase I and II clinical trials. He joined Seattle Children's Research Institute from Fred Hutchinson Cancer Research Center, where he oversaw a team responsible for performing clinical production in a clean room facility. He holds a BA from Carleton College.
Director, Research Quality Control
Stephanie Mgebroff oversees the TCPC's quality control program, ensuring that therapeutic cell products are safe and meet pre-established specifications prior to being released to the clinical team. Upon joining Seattle Children’s Research Institute, she played a key role in development of the TCPC core infrastructure and standard procedures, including quality control policy development and implementation. Mgebroff has over 12 years of cell therapy and protocol development experience. Prior to joining Seattle Children’s in 2011, she worked at both the Fred Hutchinson Cancer Research Center's cellular processing facility and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins School of Medicine. She holds an MS from Johns Hopkins University.